Searching for the Holy Grail of oncology.
Higa
Gerald M
GM
School of Pharmacy and Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV 26506, USA. ghiga@hsc.wvu.edu
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics*; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D003110:Colonic Neoplasms / Q000188:drug therapy*; D003967:Diarrhea / Q000139:chemically induced / Q000235:genetics; D020022:Genetic Predisposition to Disease; D014453:Glucuronosyltransferase / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D000077146:Irinotecan; D009503:Neutropenia / Q000139:chemically induced / Q000235:genetics; D010597:Pharmacogenetics / Q000639:trends; D020641:Polymorphism, Single Nucleotide; D018570:Risk Assessment; D000099148:UGT1A1 Enzyme
D000970:Antineoplastic Agents; D002166:Camptothecin; D014453:Glucuronosyltransferase; D000077146:Irinotecan; D000099148:UGT1A1 Enzyme